
TY  - JOUR
TI  - Focus Group
JO  - Transplant International
JA  - Transpl Int
VL  - 32
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13513
DO  - doi:10.1111/tri.13513
SP  - 127
EP  - 158
PY  - 2019
ER  - 

TY  - JOUR
TI  - Plenary Lectures
JO  - Haemophilia
VL  - 2
IS  - s1
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.1996.tb00153.x
DO  - doi:10.1111/j.1365-2516.1996.tb00153.x
SP  - 1
EP  - 150
PY  - 1996
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Ophthalmologica
JA  - Acta Ophthalmol
VL  - 97
IS  - S262
SN  - 1755-375X
UR  - https://doi.org/10.1111/aos.14061
DO  - doi:10.1111/aos.14061
SP  - 3
EP  - 41
PY  - 2019
ER  - 

TY  - JOUR
TI  - III. MODERATED POSTERS ABSTRACTS
JO  - The Journal of Sexual Medicine
VL  - 1
IS  - s1
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2004.04056.x
DO  - doi:10.1111/j.1743-6109.2004.04056.x
SP  - 61
EP  - 98
PY  - 2004
ER  - 

TY  - JOUR
TI  - ASPC Abstracts Supplement
JO  - Clinical Cardiology
JA  - Clin Cardiol
VL  - 42
IS  - S2
SN  - 0160-9289
UR  - https://doi.org/10.1002/clc.23281
DO  - doi:10.1002/clc.23281
SP  - S36
EP  - S49
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Abstract Sessions
JO  - Allergy
VL  - 66
IS  - s94
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2011.02604.x
DO  - doi:10.1111/j.1398-9995.2011.02604.x
SP  - 1
EP  - 104
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 26
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2012.01032.x
DO  - doi:10.1111/j.1472-8206.2012.01032.x
SP  - 1
EP  - 122
PY  - 2012
ER  - 

TY  - JOUR
TI  - CLINICAL NUTRITION WEEK 2015: Long Beach, CA February 14–17, 2015
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 39
IS  - 2
SN  - 0148-6071
UR  - https://doi.org/10.1177/0148607114563917
DO  - doi:10.1177/0148607114563917
SP  - 231
EP  - 256
PY  - 2015
ER  - 

TY  - JOUR
TI  - Discussed Poster Abstracts
JO  - Fundamental & Clinical Pharmacology
JA  - Fundam Clin Pharmacol
VL  - 28
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/fcp.12065
DO  - doi:10.1111/fcp.12065
SP  - 30
EP  - 90
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster session 1
JO  - European Journal of Neurology
VL  - 14
IS  - s1
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2007.01936.x
DO  - doi:10.1111/j.1468-1331.2007.01936.x
SP  - 32
EP  - 163
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Nephrology
VL  - 15
IS  - s3
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2010.01337.x
DO  - doi:10.1111/j.1440-1797.2010.01337.x
SP  - 62
EP  - 144
PY  - 2010
ER  - 

TY  - JOUR
TI  - Keyword Index
JO  - Clinical Microbiology and Infection
VL  - 11
IS  - s2
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2005.01163.x
DO  - doi:10.1111/j.1469-0691.2005.01163.x
SP  - 771
EP  - 783
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session TPS 1-18
JO  - Allergy
JA  - Allergy
VL  - 71
IS  - S102
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12974
DO  - doi:10.1111/all.12974
SP  - 300
EP  - 389
PY  - 2016
ER  - 

TY  - JOUR
TI  - ePoster Sessions
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 25
IS  - S2
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.13699
DO  - doi:10.1111/ene.13699
SP  - 90
EP  - 276
PY  - 2018
ER  - 

TY  - JOUR
TI  - 2018 IERI International Conference on Medical Physics, Medical Engineering and Informatics
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 123
IS  - S3
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.13100
DO  - doi:10.1111/bcpt.13100
SP  - 3
EP  - 111
PY  - 2018
ER  - 

TY  - JOUR
TI  - 21st Annual Meeting of the Wound Healing Society SAWC-Spring/WHS Joint Meeting
JO  - Wound Repair and Regeneration
VL  - 19
IS  - 2
SN  - 1067-1927
UR  - https://doi.org/10.1111/j.1524-475X.2010.00670.x
DO  - doi:10.1111/j.1524-475X.2010.00670.x
SP  - A8
EP  - A62
PY  - 2011
ER  - 

TY  - JOUR
AU  - Danikas, D. D.
AU  - Karakantza, M.
AU  - Theodorou, G. L.
AU  - Sakellaropoulos, G. C.
AU  - Gogos, C. A.
TI  - Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression
JO  - Clinical & Experimental Immunology
VL  - 154
IS  - 1
SN  - 0009-9104
UR  - https://doi.org/10.1111/j.1365-2249.2008.03737.x
DO  - doi:10.1111/j.1365-2249.2008.03737.x
SP  - 87
EP  - 97
KW  - flow cytometry/FACS
KW  - infections
KW  - neutrophils
KW  - phagocytosis
KW  - phenotype/cell markers
PY  - 2008
AB  - Summary The role of the phagocytic function of monocytes and neutrophils in sepsis has been poorly investigated. The present study evaluated the impact of the phagocytic activity of neutrophils and monocytes on the outcome of patients with severe sepsis. Thirty-one patients and 30 healthy individuals were enrolled in the study. The phagocytic activity of monocytes and neutrophils was evaluated during 24?h after admission and the results were correlated to the expression of CD64 on neutrophils and monocytes, CD14 antigen on monocytes, the Simplified Acute Physiology Score II and the patients' survival. A reduced phagocytic activity of neutrophils during the first 24?h after admission was a negative predictor for survival. Increased expression of CD64 antigen on polymorphonuclear cells (PMNs) and monocytes was favourably correlated to the patients' survival. In multivariate analysis the phagocytic activity of PMNs was the only independent predictor factor for survival. Patients with PMN phagocytic activity <37% had lower expression of CD64 on monocytes and PMNs and worse outcome, while those with phagocytic activity >37% had higher expression of CD64 on monocytes and PMNs and better outcome. Reduced phagocytic activity of neutrophils may represent a state of neutrophil inactivation similar to that previously described for monocytes during the compensatory anti-inflammatory response.
ER  - 

TY  - JOUR
TI  - Abstracts Oral Presentations – Educational Day
JO  - Clinical & Experimental Immunology
VL  - 154
IS  - s1
SN  - 0009-9104
UR  - https://doi.org/10.1111/j.1365-2249.2008.03767.x
DO  - doi:10.1111/j.1365-2249.2008.03767.x
SP  - 1
EP  - 224
PY  - 2008
ER  - 

TY  - JOUR
AU  - Neufeld, Eva
AU  - Viau, Katelynn A.
AU  - Hirdes, John P.
AU  - Warry, Wayne
TI  - Predictors of frequent emergency department visits among rural older adults in Ontario using the Resident Assessment Instrument-Home Care
JO  - Australian Journal of Rural Health
JA  - Aust J Rural Health
VL  - 24
IS  - 2
SN  - 1038-5282
UR  - https://doi.org/10.1111/ajr.12213
DO  - doi:10.1111/ajr.12213
SP  - 115
EP  - 122
KW  - administrative health data
KW  - home care
KW  - hospital
KW  - rural older adult
PY  - 2016
AB  - Abstract Objective To describe factors predicting frequent emergency department (ED) use among rural older adults receiving home care services in Ontario, Canada. Design A cross-sectional examination of Ontario hospital administrative data linked to provincial home care data compares frequent ED users (i.e. >4 visits/year) with regular users (i.e. 1?3 visits/year) and no ED use over a 1-year period. Multiple logistic regression analysis was performed using independent variables from home care health assessments. Main outcome measures Predictors of frequent ED use among rural older adults receiving home care services using adjusted odds ratios (ORs) and 95% confidence intervals (CI). Results Ontario's rural home care clients visited the ED an average of 4.9 times (SD?=?11.9) over a year. Frequent ED users were observed in 170 cases per 1000 home care clients. Congestive heart failure was the most frequently cited reason for frequent ED use; however, it was not a main driver in the adjusted model. Frequent ED use was predicted by younger age (i.e. 60?74 years) (OR?=?1.9; 95% CI, 1.7?2.2), a recent ED visit in the last 3 months (OR?=?1.5; 95% CI, 1.4?1.7), regularly taking >9 medications (OR?=?1.5; 95% CI, 1.3?1.6), and poor self-rated health (OR?=?1.4; 95% CI, 1.2?1.5). Conclusion Despite popular assumptions, the main drivers for frequent ED use among rural older adults in Ontario included a mix of sociodemographic and clinical characteristics, rather than disease diagnoses.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Clinical Microbiology and Infection
VL  - 10
IS  - s3
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2004.0902a.x
DO  - doi:10.1111/j.1469-0691.2004.0902a.x
SP  - 1
EP  - 86
PY  - 2004
ER  - 
